ATE178615T1 - Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen - Google Patents
Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzenInfo
- Publication number
- ATE178615T1 ATE178615T1 AT95402697T AT95402697T ATE178615T1 AT E178615 T1 ATE178615 T1 AT E178615T1 AT 95402697 T AT95402697 T AT 95402697T AT 95402697 T AT95402697 T AT 95402697T AT E178615 T1 ATE178615 T1 AT E178615T1
- Authority
- AT
- Austria
- Prior art keywords
- decapeptide
- contg
- leu
- benzodiazepincic
- action
- Prior art date
Links
- 230000037213 diet Effects 0.000 title 1
- 235000005911 diet Nutrition 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000013589 supplement Substances 0.000 title 1
- 239000000413 hydrolysate Substances 0.000 abstract 2
- 102100038920 Alpha-S1-casein Human genes 0.000 abstract 1
- SKGURMFKEAFAGD-CSYZDTNESA-N C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 SKGURMFKEAFAGD-CSYZDTNESA-N 0.000 abstract 1
- 101000741048 Homo sapiens Alpha-S1-casein Proteins 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9414362A FR2727315A1 (fr) | 1994-11-30 | 1994-11-30 | Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE178615T1 true ATE178615T1 (de) | 1999-04-15 |
Family
ID=9469315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95402697T ATE178615T1 (de) | 1994-11-30 | 1995-11-30 | Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5846939A (OSRAM) |
| EP (1) | EP0714910B1 (OSRAM) |
| JP (1) | JP3973244B2 (OSRAM) |
| AT (1) | ATE178615T1 (OSRAM) |
| DE (1) | DE69508890T2 (OSRAM) |
| DK (1) | DK0714910T3 (OSRAM) |
| ES (1) | ES2135023T3 (OSRAM) |
| FR (1) | FR2727315A1 (OSRAM) |
| GR (1) | GR3030650T3 (OSRAM) |
| SI (1) | SI0714910T1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465432B1 (en) * | 2000-08-28 | 2002-10-15 | Kraft Food Holdings, Inc. | Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides |
| EP1275308A1 (en) * | 2001-07-13 | 2003-01-15 | The Procter & Gamble Company | Food composition offering stress relaxation to mammals |
| NL1032322C2 (nl) * | 2006-08-15 | 2008-02-18 | Friesland Brands Bv | Slaapmelk. |
| FR2909879B1 (fr) * | 2006-12-13 | 2009-03-13 | Lorraine Inst Nat Polytech | Utilisation d'un heptapeptide a activite anxiolytique pour la preparation de medicaments et de complements alimentaires |
| FR2932090B1 (fr) * | 2008-06-06 | 2012-09-14 | Lorraine Inst Nat Polytech | Compositions anxiolytiques comprenant des peptides derives de la caseine alpha s1 |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
| WO2017192843A1 (en) | 2016-05-06 | 2017-11-09 | Physician's Seal, LLC | Valerian composition and related methods |
| US10980269B2 (en) * | 2016-12-12 | 2021-04-20 | Mead Johnson Nutrition Company | Protein hydrolysates and methods of making same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208240A (en) * | 1991-03-12 | 1993-05-04 | Merrell Dow Pharmaceuticals Inc. | 8-substituted purines as selective adenosine receptor agents |
| JPH06239888A (ja) * | 1993-02-18 | 1994-08-30 | Kanebo Ltd | 新規ペプチド及び鎮静剤並びに精神安定用食品 |
-
1994
- 1994-11-30 FR FR9414362A patent/FR2727315A1/fr active Granted
-
1995
- 1995-11-27 US US08/562,979 patent/US5846939A/en not_active Expired - Lifetime
- 1995-11-30 DK DK95402697T patent/DK0714910T3/da active
- 1995-11-30 EP EP95402697A patent/EP0714910B1/fr not_active Expired - Lifetime
- 1995-11-30 DE DE69508890T patent/DE69508890T2/de not_active Expired - Lifetime
- 1995-11-30 AT AT95402697T patent/ATE178615T1/de active
- 1995-11-30 SI SI9530273T patent/SI0714910T1/xx unknown
- 1995-11-30 JP JP31317695A patent/JP3973244B2/ja not_active Expired - Lifetime
- 1995-11-30 ES ES95402697T patent/ES2135023T3/es not_active Expired - Lifetime
-
1999
- 1999-06-30 GR GR990401736T patent/GR3030650T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2135023T3 (es) | 1999-10-16 |
| FR2727315B1 (OSRAM) | 1997-02-14 |
| JP3973244B2 (ja) | 2007-09-12 |
| SI0714910T1 (en) | 1999-10-31 |
| JPH08268903A (ja) | 1996-10-15 |
| GR3030650T3 (en) | 1999-10-29 |
| US5846939A (en) | 1998-12-08 |
| DK0714910T3 (da) | 1999-10-18 |
| DE69508890D1 (de) | 1999-05-12 |
| DE69508890T2 (de) | 1999-10-07 |
| FR2727315A1 (fr) | 1996-05-31 |
| EP0714910A1 (fr) | 1996-06-05 |
| EP0714910B1 (fr) | 1999-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0339656A3 (en) | Lactalbumin as food supplement | |
| ES2132158T3 (es) | Producto enterico nutritivo. | |
| FR2634104B1 (fr) | Hydrolysat partiel de proteines de lactoserum, procede enzymatique de preparation de cet hydrolysat, et aliment lacte dietetique hypoallergenique le contenant | |
| ES2150925T3 (es) | Productos alimenticios y piensos que contienen inhibidores de la lipasa. | |
| DK0626177T3 (da) | Ernæring til personer inficeret med humant immundefekt-virus | |
| AU6948198A (en) | High beta-conglycinin products and their use | |
| DE3778699D1 (de) | Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ. | |
| DK0626176T3 (da) | Næringsmiddel til personer, som undergår stråleterapi eller kemoterapi | |
| ATA285187A (de) | Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel | |
| DK119785D0 (da) | Insulinpraeparat | |
| DE69508890D1 (de) | Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen | |
| WO1988003150A3 (en) | N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration | |
| ATE6728T1 (de) | Fleischersatzprodukte, verfahren zur herstellung von fleischersatzprodukten und solche fleischersatzprodukte enthaltende fleischprodukte. | |
| ATE137110T1 (de) | Kosmetische zusammensetzung zur erhaltung der frisur enthaltend ein milchprotein und/oder ein milchproteinhydrolysate und ein hydrolysate | |
| ATE90522T1 (de) | Proteinhaltige zusammensetzung. | |
| ATE329500T1 (de) | Verwendung eines organspezifischen ernährungmittels | |
| ES2067058T3 (es) | Tratamiento de carnes. | |
| IT8786215A0 (it) | Prodotto alimentare dietetico yogurt dessert all'uovo ed affini, con procedimento di conservazione edi produzione industriale | |
| ES2033178A1 (es) | Producto dietetico y procedimiento para preparacion del mismo. | |
| ATE60698T1 (de) | Verfahren zur herstellung eines hitzebestaendigen, nicht-bitteren, wasserloeslichen peptidproduktes, das produkt, durch das verfahren hergestellt und das produkt enthaltende naehrstoffe, erfrischungen und diaetprodukte. | |
| RO114865B1 (ro) | Procedeu de preparare a unui produs biostimulator, pe bază de ouă de păsări | |
| CA861444A (en) | Poultry flavor comprising amino acids, sugars, vegetable protein hydrolysate and 5'-ribonucleotides | |
| FI873546L (fi) | Foerfarande foer framstaellning av vaermeresistanta, icke-bittra, vattenloesliga peptidprodukter, produkten framstaelld med foerfarandet och naeringsmedel, foerfriskningsmedel och dietkoster innehaollande produkten. | |
| ITRM910310A0 (it) | Procedimento per la confezione finale di insaccati in genere, particolarmente salami, e prodotto relativo. | |
| ATE105143T1 (de) | Herstellung von vergorenen nahrungsmittelerzeugnissen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner |